deltatrials
Active Not Recruiting OBSERVATIONAL NCT06561334

Spasmodic Dysphonia Interviews

The Socioeconomic Impact of Spasmodic Dysphonia Patients and the Role of Botulinum Toxin

Sponsor: Manchester University NHS Foundation Trust

Conditions Quality of Life Spasmodic Dysphonia
Interventions Botulinum toxin injections
Updated 2 times since 2024 Last updated: Sep 23, 2025 Started: Aug 20, 2024 Primary completion: Aug 31, 2025 Completion: Sep 30, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Quality of Life and Spasmodic Dysphonia, this trial is ongoing. The trial is conducted by Manchester University NHS Foundation Trust and has accumulated 2 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Sep 2024 – ~Oct 2025 · 13 months · monthly snapshotNot Yet Recruiting~Oct 2025 – present · 11 months · monthly snapshotActive Not Recruiting

Change History

2 versions recorded

  1. Oct 2025 — Present [monthly]

    Active Not Recruiting

    Status: Not Yet Recruiting → Active Not Recruiting

  2. Sep 2024 — Oct 2025 [monthly]

    Not Yet Recruiting

    First recorded

Aug 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Manchester University NHS Foundation Trust
Data source: Manchester University NHS Foundation Trust

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations